Tregitope 084 – Immunology – Antigens/Epitotes/Pools/Librairies

T regulatory cell epitopes (Tregitopes) are a set of natural T cell epitopes derived from immunoglobulin G. These peptides are Treg-activating and show some promise in prophylactic and therapeutic studies in type 1 diabetes mellitus: which is associated with effector T cell (Teff) destruction of insulin-producing pancreatic β-islet cells. In non-diabetics, self-reactive T cells are deleted during thymic development, rendered anergic, or converted into natural regulatory T cells (Tregs) that suppress autoimmune responses. Tregitopes are processed and presented by MHC class II molecules. They can suppress effector T cell responses, and up-regulate Treg-associated cytokines and chemokines. Tregitopes help stimulate ‘antigen-specific adaptive tolerance induction’ (ASATI) to modulate antigen-specific transplant rejection and to reduce immune responses to allergens in vitro and in vivo. Tregitope 289 is also available in our catalogue.

 

Technical specification

 KD20 peptide Sequence : H-GTDFTLTISSLQPED-OH
 KD20 peptide MW : 1.622.8 g/mol
 KD20 peptide Purity : > 95%
 KD20 peptide Counter-Ion : TFA Salts
Peptide library synthesis KD20 peptide Delivery format : Lyophilized

Price

 

Product Size Price €
Price $
CRB1001653-0.5 mg 0.5 mg 141 € 113 $
CRB1001653-1 mg 1 mg 193 € 154 $
CRB1001653-
CRB1001653-
CRB1001653-

For Bulk Orders